The price-to-earnings ratio for Clorox Co (NYSE: CLX) is above average at 37.60x, Company’s 36-month beta value is 0.60.Analysts have differing opinions on the stock, with 2 analysts rating it as a “buy,” 2 as “overweight,” 14 as “hold,” and 1 as “sell.”
The public float for CLX is 122.81M, and currently, short sellers hold a 2.88% ratio of that floaft. The average trading volume of CLX on April 25, 2025 was 1.56M shares.
CLX) stock’s latest price update
Clorox Co (NYSE: CLX) has seen a decline in its stock price by -1.11 in relation to its previous close of 139.11. However, the company has experienced a 0.56% gain in its stock price over the last five trading sessions. fool.com reported 2025-04-18 that Clorox (CLX 2.06%) thrived during the pandemic but has had trouble generating growth ever since.
CLX’s Market Performance
Clorox Co (CLX) has seen a 0.56% rise in stock performance for the week, with a -2.96% decline in the past month and a -14.46% plunge in the past quarter. The volatility ratio for the week is 2.43%, and the volatility levels for the past 30 days are at 2.66% for CLX. The simple moving average for the past 20 days is -3.09% for CLX’s stock, with a -10.81% simple moving average for the past 200 days.
Analysts’ Opinion of CLX
Many brokerage firms have already submitted their reports for CLX stocks, with Wells Fargo repeating the rating for CLX by listing it as a “Equal Weight.” The predicted price for CLX in the upcoming period, according to Wells Fargo is $157 based on the research report published on January 07, 2025 of the current year 2025.
TD Cowen, on the other hand, stated in their research note that they expect to see CLX reach a price target of $170, previously predicting the price at $155. The rating they have provided for CLX stocks is “Hold” according to the report published on November 06th, 2024.
Jefferies gave a rating of “Buy” to CLX, setting the target price at $187 in the report published on October 01st of the previous year.
CLX Trading at -6.07% from the 50-Day Moving Average
After a stumble in the market that brought CLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -19.72% of loss for the given period.
Volatility was left at 2.66%, however, over the last 30 days, the volatility rate increased by 2.43%, as shares sank -3.78% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.27% lower at present.
During the last 5 trading sessions, CLX rose by +0.56%, which changed the moving average for the period of 200-days by +3.55% in comparison to the 20-day moving average, which settled at $141.95. In addition, Clorox Co saw -15.29% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CLX starting from Marriner Kirsten, who sale 7,494 shares at the price of $151.62 back on Mar 10 ’25. After this action, Marriner Kirsten now owns 27,038 shares of Clorox Co, valued at $1,136,251 using the latest closing price.
Marriner Kirsten, the EVP – Chief People Officer of Clorox Co, sale 733 shares at $150.00 during a trade that took place back on Mar 11 ’25, which means that Marriner Kirsten is holding 26,305 shares at $109,950 based on the most recent closing price.
Stock Fundamentals for CLX
Current profitability levels for the company are sitting at:
- 0.18 for the present operating margin
- 0.45 for the gross margin
The net margin for Clorox Co stands at 0.06. The total capital return value is set at 0.33. Equity return is now at value 7616.67, with 7.96 for asset returns.
Based on Clorox Co (CLX), the company’s capital structure generated 1.01 points at debt to capital in total, while cash flow to debt ratio is standing at 0.3. The debt to equity ratio resting at -75.41. The interest coverage ratio of the stock is 14.83.
Currently, EBITDA for the company is 736.0 million with net debt to EBITDA at 2.9. When we switch over and look at the enterprise to sales, we see a ratio of 2.76. The receivables turnover for the company is 11.88for trailing twelve months and the total asset turnover is 1.28. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.94.
Conclusion
In a nutshell, Clorox Co (CLX) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
